recombinant hepatitis b vaccine

BIOLOGICAL5 trials

Sponsors

Novartis Vaccines, Beijing Center for Disease Control and Prevention, PT Bio Farma, National Taiwan University Hospital, Jiangsu Province Centers for Disease Control and Prevention

Conditions

Hand, Foot and Mouth DiseaseHealthyHepatitis AHepatitis BImmunogenicityMeningococcal DiseaseMeningococcal MeningitisPreventable Disease, Vaccine

Phase 2

Protectivity and Safety Following Recombinant Hepatitis B Vaccine

CompletedNCT03919578

PT Bio FarmaImmunogenicity

Start: 2019-09-11End: 2020-02-28Updated: 2022-09-19

Phase 3

Study to Evaluate the Safety and Immunogenicity of Combined Hepatitis A/B Vaccine With MenACWY-CRM Conjugate Vaccine

CompletedNCT01453348

Novartis VaccinesHepatitis A, Hepatitis B, Meningococcal Disease +1

Start: 2011-10-31End: 2012-01-31Updated: 2017-06-08

Phase 4

Safety and Immunogenicity Study of Aleph Inactivated Split Influenza Vaccine

CompletedNCT01758185

Beijing Center for Disease Control and PreventionHealthy

Start: 2011-08-31End: 2012-12-31Updated: 2013-03-28

Immunogenicity of the Inactivated EV71 Vaccine Combined With Hepatitis B and Group A Meningococcal Vaccine

Active, not recruitingNCT06209398

Jiangsu Province Centers for Disease Control and PreventionHand, Foot and Mouth Disease

Start: 2018-05-24End: 2025-12-31Updated: 2024-01-17

Unknown Phase

The Immune Responses After Hepatitis B Revaccination Doses in a Young Cohort

RecruitingNCT04970836

National Taiwan University HospitalHepatitis B, Preventable Disease, Vaccine, Vaccination; Infection

Start: 2021-08-01End: 2027-12-31Target: 240Updated: 2025-03-20

Related Papers

Immunological persistence of a seasonal influenza vaccine in people more than 3 years old

Human Vaccines & Immunotherapeutics2015-06-177 citations

Immunogenicity and Safety of Concomitant Administration of a Combined Hepatitis A/B Vaccine and a Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adults

Journal of Travel Medicine2014-12-0913 citations